Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDECABTAGENE VICLEUCEL Cause Covid-19? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Covid-19 have been filed in association with IDECABTAGENE VICLEUCEL (Abecma). This represents 0.8% of all adverse event reports for IDECABTAGENE VICLEUCEL.

8
Reports of Covid-19 with IDECABTAGENE VICLEUCEL
0.8%
of all IDECABTAGENE VICLEUCEL reports
3
Deaths
4
Hospitalizations

How Dangerous Is Covid-19 From IDECABTAGENE VICLEUCEL?

Of the 8 reports, 3 (37.5%) resulted in death, 4 (50.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Covid-19 Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDECABTAGENE VICLEUCEL. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does IDECABTAGENE VICLEUCEL Cause?

Cytokine release syndrome (607) Immune effector cell-associated neurotoxicity syndrome (176) Fatigue (159) Neurotoxicity (70) Neutropenia (68) Pyrexia (67) Anaemia (63) Decreased appetite (54) Headache (54) Hypogammaglobulinaemia (54)

What Other Drugs Cause Covid-19?

NIRMATRELVIR\RITONAVIR (22,066) OCRELIZUMAB (11,454) ADALIMUMAB (9,138) DUPILUMAB (6,986) RITUXIMAB (6,301) LENALIDOMIDE (6,223) TOFACITINIB (4,926) SECUKINUMAB (3,871) INFLIXIMAB (3,698) TACROLIMUS (3,201)

Which IDECABTAGENE VICLEUCEL Alternatives Have Lower Covid-19 Risk?

IDECABTAGENE VICLEUCEL vs IDELALISIB IDECABTAGENE VICLEUCEL vs IDURSULFASE IDECABTAGENE VICLEUCEL vs IFOSFAMIDE IDECABTAGENE VICLEUCEL vs IGURATIMOD IDECABTAGENE VICLEUCEL vs ILOPERIDONE

Related Pages

IDECABTAGENE VICLEUCEL Full Profile All Covid-19 Reports All Drugs Causing Covid-19 IDECABTAGENE VICLEUCEL Demographics